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Virion IncorporationHSV-1 virions contain a proteinaceous layer termed the tegument that lies between the nucleocapsid and
viral envelope. The molecular mechanisms that facilitate incorporation of tegument proteins are poorly
characterized. The tegument protein VP22 interacts with VP16 and the cytoplasmic tail of glycoprotein E
(gE). Virion incorporation of VP22 occurs independently of interaction with VP16; however, the contribution
of gE binding remains undeﬁned. Site-directed mutagenesis was used to identify VP22 mutants which
abrogate interaction with gE but retain VP16 binding. Virion incorporation assays demonstrated that failure
to bind gE did not abrogate VP22 packaging. A region of VP22 which binds to both VP16 and gE failed to be
packaged efﬁciently, with wild-type levels of incorporation only attained when residues 43–86 of VP22 were
present. Mutational analysis of an acidic cluster of amino acids within this region indicates that this motif
facilitates trans-Golgi network (TGN) localization and optimal virion incorporation of VP22.logy and Immunology, The
University Drive, Hershey, PA
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Assembly of herpes simplex virus type 1 (HSV-1) involves an
intricate sequence of events, which coordinate incorporation of over 40
different viral proteins into one of three morphologically distinct virion
structures: the nucleocapsid, the host-derived lipid envelope containing
virally encodedglycoproteins, and the tegument, a proteinaceous region
located between the nucleocapsid and envelope (Roizman and Pellett,
2001). Although, extensive studies have established that capsid
assembly and packaging of the viral genome occur in the nucleus, the
compartment(s) in which the tegument and envelope are acquired is
less well deﬁned (Enquist et al., 1998; Mettenleiter, 2002; Mettenleiter
et al., 2009). The currentmodel for HSV-1 assembly and egress suggests
that nucleocapsids are exported to the cytoplasm via a budding/fusion
event that occurs across the inner and outermembranes of the nucleus,
respectively. Unenveloped nucleocapsids subsequently transit through
the cytoplasm until they reach a trans-Golgi network (TGN)-derived
vesicle, where a budding event results in concurrent acquisition of a
ﬁnal lipid bilayer and complement of viral glycoproteins (Sanchez et al.,
2000; Skepper et al., 2001; van Genderen et al., 1994; Whealy et al.,1991; Whiteley et al., 1999). Ultimately, virion-containing vesicles
follow the secretory pathway to the cell surface, where mature virus
particles are released into the extracellular milieu (Mettenleiter, 2002;
Mettenleiter et al., 2009).
In contrast to nucleocapsid assembly, the molecular mechanisms
that facilitate addition of tegument proteins to the nucleocapsid during
the assembly pathway and the process of ﬁnal envelopment itself are
poorly understood (Mettenleiter, 2002; Mettenleiter et al., 2009;
Roizman and Pellett, 2001). Tegumentation of nucleocapsids can
theoretically occur at various stages in the egress pathway: in the
nucleus, at the nuclear membrane, in the cytoplasm, or during budding
at the TGN. Recent studies have demonstrated that a subset of tegument
proteins are added to the capsid prior to nuclear egress; however, the
mechanism(s) by which tegument proteins are selectively packaged
into the assembling virion has yet to be deﬁned (Bucks et al., 2007;
Naldinho-Souto et al., 2006). It is likely that amyriad of protein–protein
interactions between capsid proteins, tegument proteins, and the
cytoplasmic tails of virally encoded glycoproteins facilitate the process.
Our studies have focused on deﬁning the protein–protein interaction
motifs of one speciﬁcHSV-1 tegument protein, VP22, and the roles these
interactions play in facilitating virion incorporation of the protein.
The HSV-1 UL49 gene encodes the 301-amino acid VP22, which is
one of the most abundant proteins in the tegument region (Elliott, and
Meredith, 1992; Heine et al., 1974; Leslie et al., 1996). Despite its
abundance, the role of VP22 during HSV-1 assembly and mechanism of
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viruses have been described and demonstrate a variety of cell-speciﬁc
replication defects and altered virion composition, including decreased
packaging of both glycoprotein D (gD) and glycoprotein E (gE), two
known binding partners of VP22 (Chi et al., 2005; Duffy et al., 2006;
Elliott et al., 2005; O'Regan et al., 2007a; Pomeranz and Blaho, 2000).
VP22 associates with membranes and localizes to acidic compartments
of the cell including the TGN(Brignati et al., 2003). In addition tobinding
to cytoplasmic tails of a subset of viral glycoproteins, presumably at the
TGN, VP22 is known to interact with another abundant tegument
protein, VP16(Chi et al., 2005;Elliott et al., 1995, 2005; Farnsworthet al.,
2007; O'Regan et al., 2007b; Stylianou et al., 2009). Transmission
immunoelectron microscopy (TIEM) studies suggest that during the
viral assembly pathway, detectable amounts of VP16 are added to the
capsid in the nucleus, with additional VP16 added as the nucleocapsid
moves through the cytoplasm prior to ﬁnal envelopment (Miranda-
Saksena et al., 2002; Naldinho-Souto et al., 2006). In contrast, VP22 is
packaged into virions during ﬁnal envelopment, as nucleocapsids bud
into TGN-derived vesicles (Miranda-Saksena et al., 2002). These
ﬁndings suggest that interaction between VP22 and viral glycoproteins
on the cytoplasmic face of the TGN vesicle, perhaps in concert with
binding to tegument proteins located on the surface of the approaching
capsid (such as VP16), may ensure accrual of VP22 in the tegument and
facilitate ﬁnal envelopment.
A VP22 construct deﬁcient for VP16 binding but competent for
interaction with the cytoplasmic tail of gE is still packaged into
assembling HSV-1 particles (O'Regan et al., 2007b). Interestingly,
simultaneous deletion of pseudorabies virus (PRV) gM and the gE/
gI heterodimer, both of which are binding partners of the PRV
VP22 homologue, results in capsid-bound tegument aggregates in
the cytoplasm and reduced amounts of VP22 in the mature PRV
particle (Brack et al., 1999, 2000; Fuchs et al., 2002). Furthermore,
the Bartha strain of PRV, which lacks glycoproteins gI and gE, fails
to package VP22 and a recent report from Stylianou and coworkers
suggests that interaction with gE is a major determinant of HSV-1
VP22 incorporation (Lyman et al., 2003; Stylianou et al., 2009).
These ﬁndings suggest that binding to the cytoplasmic tail of a
viral glycoprotein may be an important packaging determinant for
VP22.
To ascertain the contribution of gE binding to virion packaging
of HSV-1 VP22, site-directed mutagenesis was used to speciﬁcally
disrupt the VP16 and gE binding activities of the protein.
Assessment of these point mutants in a virion incorporation assay
demonstrated that failure to bind to gE did not abrogate packaging
of VP22. Furthermore, a region of VP22 which binds to both VP16
and gE, failed to be packaged to wild-type levels, with efﬁcient
levels of incorporation only attained when residues 43–86 of VP22
were present. This ﬁnding suggested the existence of additional
VP22 incorporation determinants within this domain of the protein.
Analysis of an acidic cluster of amino acids within this region
indicates that this motif facilitates recruitment of VP22 to the TGN
and is an important determinant for virion packaging.
This report provides new information on the molecular mecha-
nism by which VP22 is incorporated into virus particles and reveals
that in addition to protein–protein interactions, proper trafﬁck-
ing and localization of VP22 also contribute to efﬁcient virion
packaging.
Results
Site-directed point mutagenesis of VP22
The gE binding activity of VP22 has been mapped to a domain
encompassing residues 165 to 270, which are highly conserved
among VP22 homologues of herpesviruses and also facilitate
binding to VP16 (O'Regan et al., 2007a,b; Stylianou et al., 2009).To ascertain the contribution of gE binding to virion incorporation of
VP22, site-directed point mutagenesis was used to target conserved
residues within this domain in an attempt to abrogate gE binding
while leaving the ability to bind VP16 intact.
Two tryptophan residues at positions 189 and 221 of VP22
and phenylalanine residues at amino acids 196 and 201 were the
initial targets for mutagenesis (Fig. 1A). These targets were chosen
due to their similarity to a “WW” domain, a well-characterized
protein–protein interaction motif. “WW” domains are typically 35
to 40 amino acids in length, characterized by two tryptophan resi-
dues that bookend aromatic residues with a proline residue located
C-terminally of the second tryptophan (Ingham et al., 2005).
Interestingly, “WW” domain ligands include proline-rich peptide
motifs and phosphorylated serine/threonine-proline sites, exam-
ples of which are found in the cytoplasmic tail of gE (Harty et al.,
1999). The tryptophan residue at position 189 and/or 221 was
changed conservatively to a phenylalanine, creating the VP22
constructs W189F, W221F, and W189F/W221F (Fig. 1A). Studies
suggest that aromatic residues located between the tryptophans of a
“WW” domain confer ligand speciﬁcity to this protein–protein
interaction motif (Ilsley et al., 2002; Verdecia et al., 2000). Thus,
phenylalanines at positions 196 and 201 of VP22 were mutated to
either alanines (F196A and F201A) or more conservatively to
tryptophan residues (F196W and F201W) (Fig. 1A). Localization
studies demonstrated that all mutant constructs displayed a
subcellular localization reminiscent of wild-type VP22 in trans-
fected/infected cells (data not shown). Thus, failure of any mutant
to bind VP16/gE or to be incorporated into the virus particle is not
due to a gross mislocalization within the cell.
Characterization of the ability of VP22 point mutants to bind to
the cytoplasmic tail of gE
To determine whether mutation of the conserved tryptophan or
phenylalanine residues within VP22 would abrogate binding to gE, a
glutathione S-transferase (GST) pull-down assay was utilized. The
cytoplasmic tail of gE fused to the C-terminus of the GST protein
(GST-gECT) or GST alone were expressed in Escherichia coli cells and
subsequently puriﬁed. Approximately equal amounts of GST fusion
proteins were used in the pull-down assay as determined by
Coomassie blue staining (data not shown). Vero cells were
transfected with plasmids encoding the green ﬂuorescent protein
(GFP) or the various mutants of VP22 fused to the N-terminus of GFP
represented in Fig. 1A. The transfected monolayers were lysed with
NP-40 lysis buffer, and a fraction of each cell lysate was analyzed by
Western blotting to verify that the GFP-tagged constructs were
expressed (Figs. 1B and C). The remaining lysates were incubated
with equivalent amounts of puriﬁed GST fusion proteins (either the
cytoplasmic tail of gE fused to GST or GST alone) bound to
glutathione–Sepharose beads. The beads were subsequently washed
extensively with lysis buffer, and bound material was separated by
SDS–PAGE and then analyzed on Western blots.
Upon analysis of transfected lysates, each of the VP22 point
mutants under study demonstrated high levels of expression
(Figs. 1B and C). Curiously, a faster migrating band was detected
with the F196A construct, which was not present in lysates of other
point mutants (Fig. 1C). The band reacted with GFP antiserum
suggesting that it is GFP tagged and thus may represent a VP22
breakdown product that is stabilized by the F196A mutation. With
regard to gE binding, VP22–GFP was efﬁciently pulled-down from
transfected cell lysates by GST-gECT but not by the GST alone
control (Figs. 1 and 4F). In contrast, W189F or W189F/W221F
(Figs. 1D and F) and F196A, F201A, or F201W (Figs. 1E and F) failed
to bind to gE. F196W exhibited levels of binding to GST-gECT greater
than those seen with wild-type VP22 (approximately 140%)
(Fig. 1F), whereas the mutant W221F, although still retaining
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(Fig. 1F). Taken together, these results indicate that a variety of
conservative amino acid substitutions (W189F, W189F/W221F, andFig. 1. Characterization of the ability of VP22 point mutants to bind to the cytoplasmic ta
representation of wild-type VP22 and amino acid substitution mutants used in this study fus
transfected cells. Vero cells were transfected with the indicated constructs and 20 h post-tra
fusion proteins was analyzed by Western blotting using a rabbit polyclonal antibody spe
Approximately equal amounts of puriﬁed GST fusion proteins were added to the remainder o
proteins were separated by SDS–PAGE and transferred to nitrocellulose. Western blot analys
positions of molecular mass markers (in kilodaltons) are indicated on the left. (F) Binding efﬁ
efﬁciency was quantitated by dividing the amount of VP22–GFP protein detected in the pull-
lysate (normalized for the amount of actin present). In each experiment, the wild-type V
deviations for four replicate experiments.F201W) are capable of inhibiting VP22's ability to bind to gE and
may be useful tools in the task of deciphering the role gE binding
plays in virion incorporation of VP22.il of gE in a GST pull-down assay. (A) Point mutants of VP22 fused to GFP. Schematic
ed to the N-terminus of the GFP protein. (B and C) Expression of VP22 point mutants in
nsfection, the monolayers were lysed with NP-40 lysis buffer. Expression of VP22–GFP
ciﬁc for GFP. (D and E) GST pull-down from transfected cell lysates using GST-gECT.
f the transfected cell lysates. Beads were washed extensively with lysis buffer and bound
is was performed using a rabbit polyclonal antibody raised against the GFP protein. The
ciency of VP22 point mutants to the cytoplasmic tail of gE. Using densitometry, binding
down assay (normalized for the amount of GST-gECT present) by the amount in the cell
P22–GFP construct was set at 100% binding efﬁciency. Error bars represent standard
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in a co-immunoprecipitation assay
With the identiﬁcation of conservative amino acid substitutions
capable of abrogating VP22's binding with gE, we were anxious to test
the effect of these mutations on interaction with VP16. Our hope was
to separate the two binding activities within VP22. To this end,
immunoprecipitation assays from transfected/infected cell lysates
were performed to ascertain if the VP22 point mutants had a
deleterious effect upon interaction with VP16. The VP22 constructs
represented in Fig. 1A were transfected into Vero cells, and at 20 h
post-transfection, cells were infected with HSV-1 at an MOI of 10.
After an additional period of 10 h, the monolayers were lysed with
NP-40 lysis buffer and a fraction of each cell lysate was analyzed by
Western blotting to verify that the GFP-tagged truncation mutants
were expressed in transfected/infected cells (Figs. 2A and B). [As
noted earlier, a faster migrating band was detected with F196A which
was not present in the lysates of other point mutants (Fig. 2B)]. The
remaining lysates were then incubated with goat anti-GFP antibodies
followed by Protein G-agarose beads. Immunoprecipitated material
was separated by SDS–PAGE and analyzed by Western blotting using
rabbit anti-VP16 antibodies to assay for immunoprecipitation of VP16
with VP22 point mutants. When the VP22 point mutants were
analyzed for their ability to interact with VP16 within transfected/
infected cells, VP16 co-immunoprecipitated with W221F, F196A,
F196W, F201W, and the wild-type VP22 construct (Figs. 2C and D).Fig. 2. Co-immunoprecipitation of VP22 point mutants with VP16. (A and B) Expression
expressing GFP, VP22–GFP constructs or mock transfected cells (Mock) were infected with H
was analyzed by Western blotting using a goat polyclonal antibody speciﬁc for GFP. (C and
transfected/infected cell lysate was incubated with a goat polyclonal antibody against GFP a
After extensive washes with lysis buffer, material that immunoprecipitated with anti
immunoprecipitated VP16 was detected by immunoblot using a rabbit monospeciﬁc polyc
mass markers (in kilodaltons) are indicated on the left.W189F retained the ability to interact with VP16 (albeit poorly);
however, binding was abrogated with mutants F201A and W189F/
W221F.
Interaction of VP22 point mutants with VP16 in the absence of additional
viral proteins
The co-immunoprecipitation studies described above were per-
formed with transfected/infected cell lysates. Thus, in addition to our
mutant constructs, virally encoded VP22 is present in the experimental
system. Recent studies have suggested thatVP22maypossess the ability
tomultimerize (Mouzakitis et al., 2005; O'Regan et al., 2007b; Vittone et
al., 2005). Therefore, virally expressed VP22 could theoretically act as a
bridge between VP16 and the VP22 mutants under study. As several of
the VP22 pointmutants assayed appeared to retain the ability to bind to
VP16, we sought to examine the interaction in the absence of infection
in order to verify that the binding detected was authentic and not
facilitated by virally encoded VP22. To attain this goal, we exploited a
modiﬁed version of the GST pull-down assay described above using
VP16 fused to the C-terminus of GST (GST-VP16) as bait rather than the
cytoplasmic tail of gE. GST-VP16 and GST alonewere expressed in E. coli
cells and subsequently puriﬁed, with approximately equal amounts of
each used in the pull-down assay as determined by Coomassie blue
staining (Fig. 3A). Vero cells were transfected with plasmids encoding
GFP alone or the indicated VP22 point mutants, and a fraction of each
cell lysate was analyzed by Western blotting to verify that the GFP-of VP22 point mutants represented in Fig. 1A in transfected/infected cells. Vero cells
SV-1 and lysed 10 h post-infection with NP-40 lysis buffer. A fraction of each cell lysate
D) Co-immunoprecipitation of VP16 with VP22 point mutants. The remainder of the
nd resulting antibody–antigen complexes were collected with protein G-agarose beads.
-GFP antibody was separated by SDS–PAGE and transferred to nitrocellulose. Co-
lonal antibody raised against a C-terminal peptide of VP16. The positions of molecular
Fig. 3. Analysis of VP22 point mutants in a GST pull-down assay. (A) Coomassie-blue-stained gel of VP16 fused to the C-terminus of the GST protein (GST-VP16) and GST alone. GST-
VP16 or GST were expressed in Escherichia coli cells and puriﬁed on glutathione–Sepharose beads. Expression of VP22 point mutants represented in Fig. 1A in transfected Vero cells
(B) and their ability to bind to VP16 (C) were analyzed as described in the legend to Fig. 1 with GST-VP16 used as bait rather than GST-gECT. (D) Binding efﬁciency of VP22 point
mutants to VP16. Using densitometry, binding efﬁciency was quantitated by dividing the amount of VP22–GFP protein detected in the pull-down assay (normalized for the amount
of GST-VP16 present) by the amount in the cell lysate (normalized for the amount of actin present). In each experiment, the wild-type VP22–GFP construct was set at 100% binding
efﬁciency. Error bars represent standard deviations for four replicate experiments. The ability of each VP22 mutant to bind to gE (as determined in Fig. 1) is also represented. A plus
indicates that the mutant construct retains binding activity, whereas a minus denotes abrogation of binding.
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analyzed in the GST pull-down assay for binding to GST-VP16, with
bound material separated by SDS–PAGE and then analyzed byWestern
blotting (Fig. 3C).
VP22 fused to GFPwas efﬁciently pulled-down from transfected cell
lysates, indicating that the interaction of VP22 with VP16 can occur in
the absence of additional viral proteins (Figs. 3C and D). In agreement
with the results of co-immunoprecipitation studies,W189F/W221F and
F201A, point mutants which abrogated interaction with gE, failed to
bind to VP16 to levels above background (Figs. 3C and D). In contrast,
W221F and F196W, which bind to gE at levels approaching 54% and
140% of wild-type VP22, respectively, were efﬁciently pulled-down by
GST-VP16 (Figs. 3C and D). Interestingly, the levels of binding to VP16
observed with these mutants parallel those seen with gE binding.
W221F bound to VP16 at approximately 41% of wild-type VP22 levels,
with F196Wmore efﬁcient at 130% (Fig. 3D). It is appealing to speculate
that the apparent repressive and enhancing effects these mutants
display upon VP16 and gE binding may be due to their impact on the
structure of VP22. W221F potentially masks the gE and VP16 bindingsites, with F196Whaving the contradictory effect, exposing the binding
interfaces.
Co-immunoprecipitation experiments predicted that three VP22
mutant constructs (W189F, F196A, and F201W), which were unable
to interact with gE, would retain the ability to bind to VP16. When
these mutants were assayed for their ability to bind to GST-VP16, as
expected W189F demonstrated a binding efﬁciency of 77% of wild-
type VP22, and F196A and F201W exhibited levels of 84% and 87%,
respectively (Figs. 3C and D). Interestingly, the faster migrating band
that was observed upon expression of F196A in our previous
experiments was also detected in this assay and was efﬁciently
pulled-down by the GST-VP16 fusion protein (Fig. 3C), suggesting that
this putative breakdown product of VP22 may possess the ability to
bind to VP16.
Collectively, our analysis of VP22 point mutants suggests that the
VP16 binding activity housed within the conserved central region of
VP22 can be separated from the gE binding activity by mutation of a
tryptophan residue at position 189, or one of two phenylalanine
residues at positions 196 or 201.
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virion incorporation of VP22
Previously,wehave shown that incorporationofVP22 into assembling
virus particles is independent of interaction with VP16 (O'Regan et al.,
2007b). A recent report described a VP22 construct containing an internal
deletion which failed to bind to gE and demonstrated reduced virion
packaging, suggesting that interaction with gE may be a major
determinant of HSV-1 VP22 incorporation (Stylianou et al., 2009).
With the identiﬁcation of VP22 constructs containing point muta-
tions that abrogate gE binding yet retain the ability to interact efﬁciently
with VP16, we now possess the tools to further examine the role gE
bindingplays in virion incorporation of VP22. Due to thevolumeofVP22
constructs assayed in this study, it was impractical to examine the
various mutant alleles using recombinant viruses. Thus, to accomplishFig. 4. Virion incorporation of VP22 W→F and F→A/W point mutants in the absence of vira
and 20 h later, they were infected with a VP22-null virus [UL49−]. After an additional 18-h in
centrifugation through a 30% sucrose cushion (B). Cell lysates and extracellular virus were
performed using a rabbit polyclonal antibody speciﬁc for GFP. As a loading control, the blot w
the HSV-1 major capsid protein VP5. The positions of molecular mass markers (in kilodalto
efﬁciency was quantitated by dividing the amount of VP22–GFP protein detected in extracellu
VP5). In each experiment, the wild-type VP22–GFP construct was set at 100% packaging efﬁci
of each VP22 mutant to bind to either gE (as determined in Fig. 1) or VP16 (as determined
binding activity, whereas a minus denotes abrogation of binding.our goal, we utilized a transfection/infection-based packaging assay, an
in vitro experimental system, which our group and others have used to
identify andmap numerous virion incorporation determinants (Loomis
et al., 2001, 2003, 2006; Mukhopadhyay et al., 2006; O'Regan et al.,
2007a,b). Speciﬁcally, Vero cells were transfected with plasmids
encoding various VP22–GFP fusion proteins and subsequently infected
with either a VP22-null virus (UL49−) (Fig. 4) or wild-type HSV-1 (data
not shown). The use of a VP22-null virus [a kindgift fromDr. Joel Baines,
Cornell University, Ithaca (Duffy et al., 2006)] eliminates the possibility
of multimerization between virally encoded VP22 and the mutant
construct under study that may otherwise confound the results of the
incorporation assay. At 18 h post-infection, extracellular virions were
harvested and subsequently pelleted through a sucrose cushion.
Pelleted virions were analyzed by Western blotting using GFP-speciﬁc
antisera to detect VP22–GFP fusion proteins. To conﬁrm thatlly encoded VP22. Vero cells were transfected with the indicated VP22–GFP constructs,
cubation, cell lysates were prepared (A), and virions were collected from the media by
separated by SDS–PAGE and transferred to nitrocellulose. Western blot analysis was
as stripped and reprobed with a rabbit monospeciﬁc polyclonal antibody raised against
ns) are indicated on the left. (C) Packaging efﬁciency. Using densitometry, packaging
lar virus particles (normalized for VP5) by the amount in the cell lysate (normalized for
ency. Error bars represent standard deviations for four replicate experiments. The ability
in Fig. 2 and 3) is also represented. A plus indicates that the mutant construct retains
182 K.J. O'Regan et al. / Virology 405 (2010) 176–192approximately equal amounts of virus were loaded with each sample,
Western blots were stripped and reprobed for the major capsid protein
VP5.
Analysis of the VP22–GFP constructs within transfected/infected
cells showed that they were expressed at levels similar to the wild-
type construct and migrated at the expected molecular weight
(Fig. 4A). With regard to packaging, similar results were seen with
both the VP22-null virus (Fig. 4B) and wild-type HSV-1 (data not
shown), suggesting that multimerization with virally encoded VP22
does not facilitate incorporation of the point mutants into the virus
particle. Speciﬁcally, wild-type VP22–GFP was incorporated into virus
particles, whereas GFP alone was undetectable, despite high expres-
sion in transfected/infected cells, indicating that GFP itself does not
have a signiﬁcant effect on packaging (Figs.4B and C). Furthermore,
none of the VP22–GFP mutant proteins were detected in media from
transfected/mock-infected cells (data not shown), and prior utiliza-
tion of this assay has demonstrated that many constructs fail to be
packaged upon infection, indicating that incorporation is in fact a
speciﬁc event and not due to aggregates that can pellet through the
sucrose cushion (Loomis et al., 2006; O'Regan et al., 2007a,b). The
VP22 mutant constructs W189F/W221F and F201A, which abrogated
binding of VP22 to both VP16 and gE failed to be packaged into virions
(Figs. 4B and C [UL49−]). VP22 mutants such as these, which are
deﬁcient for a variety of activities, most likely suffer from gross
conformational issues as a result of the mutation itself rather than the
identiﬁcation of a key residue involved in three singular activities of
VP22.
The VP22 mutants W221F and F196W, which retained the ability to
interact with both VP16 and gE, were packaged into assembling virus
particles but withmarkedly different efﬁciencies (Figs. 4B and C). W221F
was packaged at approximately 41% of wild-type levels with a UL49−
infection, a result presumably attributable to themutant's impaired ability
to bind VP16 (41% of wild-type VP22 levels) and gE (54% of wild-type
VP22 levels). In contrast, F196Wwhich demonstrated levels of binding to
both VP16 and gE in excess of wild-type (130% and 140%, respectively)
waspackaged intoassemblingvirusparticles at approximately120%of the
full-length VP22–GFP construct with a UL49− infection. This ﬁnding
suggests that an increase in binding to one or both binding partners of
VP22 may enhance incorporation of the protein into assembling virions.
The VP22 mutants of particular interest to this project, W189F,
F196A, and F201W (which interact with VP16 but not gE), were
incorporated into assembling virus particles albeit at levels below
wild-type VP22 (Figs. 4B and C). The reduced level of virus packaging
may be a result of the impaired ability of these mutants to bind to
VP16 (W189F ∼77%, F196A ∼84%, and F201W ∼87%), possibly
complemented by their failure to bind to gE. Interestingly, the faster
migrating band detected upon expression of F196A, which we
hypothesize may be a breakdown product of VP22 that the mutation
stabilizes, was also incorporated into virus particles. These results
suggest that binding to the cytoplasmic tail of gE is not required for
incorporation of VP22 into assembling virus particles.
Incorporation of VP22 into virus particles is independent of interactions
with gE and VP16
Wehave previously demonstrated that VP16 binding is not required
for inclusion of VP22 into assembling virus particles (O'Regan et al.,
2007b). The observation that VP22 virion incorporation also appears to
be gE-independent suggests that perhaps the two binding activities act
in a redundant fashion to facilitate virus packaging. Alternatively, gE and
VP16 binding may be only two of a plethora of activities that ensure
recruitment of VP22 into the virus particle.
To examine whether VP16 and gE binding may act in a redundant
fashion to ensure virion incorporation of VP22 we utilized a
previously described mutant of VP22, VP22.LI (−), which abrogates
VP16 binding with minimal effects upon interaction with gE (O'Reganet al., 2007b). VP22.LI (−) was analyzed in a transfection/infection-
based packaging assay with a gE/gD-null virus [vRR1097/gEβ] [a kind
gift from David Johnson, The Oregon Health and Science University,
Portland, Oregon (Farnsworth et al., 2003)] used for infection. The gE/
gD-null virus was used rather than a wild-type virus to ensure
removal of any gE from the assay which could facilitate incorporation
of VP22.LI (−). The use of this virus necessitated the experiment to be
performed in gD-expressing cells, as no virus particles are made in the
absence of both gE and gD (Farnsworth et al., 2003). gD-expressing
Vero cells (VD60 cells) were transfected with plasmids encoding
various VP22–GFP fusion proteins and subsequently infected with the
gE/gD-null virus [vRR1097/gEβ]. At 18 h post-infection, extracellular
virions were harvested and subsequently pelleted through a sucrose
cushion. Pelleted virions were analyzed by Western blotting using
GFP-speciﬁc antisera to detect VP22–GFP fusion proteins. To conﬁrm
that approximately equal amounts of virus were loaded with each
sample, Western blots were stripped and reprobed for the major
capsid protein VP5.
Analysis of the VP22 constructs within transfected/infected cells
showed that VP22.LI (−) was expressed at levels similar to the wild-
type construct and migrated at the expected molecular weight
(Fig. 5A). With regard to packaging, despite the absence of both gE
and VP16 binding, VP22.LI (−) was packaged into assembling virus
particles albeit at levels below those of the wild-type construct
(Figs. 5B and C). The levels of incorporation of VP22.LI (−) were
marginally lower when the gE/gD-null virus was used for infection
(28%) (Fig. 5C) rather than a wild-type (33%) or VP22 KO virus (38%)
(O'Regan et al., 2007b), suggesting that the contribution of gE binding
to the incorporation of VP22 may be minimal. These results indicate
that VP22 can be incorporated into assembling virions in the absence
of interaction with VP16 and gE and that these binding activities do
not act in a redundant fashion to facilitate inclusion of VP22 into virus
particles. Furthermore, these experiments suggest the presence of
additional incorporation determinants within VP22 that contribute to
virion incorporation of the protein.
A VP22 construct that binds to both VP16 and gE at wild-type levels
is impaired for virion packaging
Previously, we demonstrated that a domain of VP22 encompassing
residues 165–270 facilitates binding to both VP16 and gE (O'Regan
et al., 2007b). Curiously, despite possessing membrane association
activity, in addition to high binding efﬁciencies to both VP16 (399% of
wild-type levels) and gE (86% of wild-type levels), this domain of
VP22 is only packaged to 54% of the levels seen with a full-length
VP22–GFP construct (O'Regan et al., 2007b). It is attractive to propose
that in order to attain wild-type levels of virion incorporation of VP22,
the construct under study must also contain the heretofore uniden-
tiﬁed incorporation determinant. In an effort to map the location of
this activity within VP22, a variety of N-terminal and C-terminal
extensions of the conserved core of VP22 (amino acids 165–270)were
tagged with GFP, creating the fusion proteins represented in Fig. 6A.
Initially, immunoprecipitation assays from transfected/infected cell
lysates were performed to ascertain if the VP22 truncation mutants
had a deleterious effect upon interaction with gE and/or VP16. Both
binding partners, gE (Fig. 6C) and VP16 (Fig. 6D), co-immunopreci-
pitated with each of the VP22 truncation mutants. These results
indicate that extension of the VP16 and gE binding domains either
toward the carboxyl or amino terminus of the VP22 fails to abrogate
VP16 or gE binding. The effect of the truncation mutants on the
binding efﬁciency of VP22 to gE and VP16 was also analyzed using the
GST-gECT and GST-VP16 pull-down assays described in Figs. 1 and 3,
respectively. Analysis of the VP22 truncation mutants in these assays
suggests that the gE binding activity housed within residues 165–270
of VP22 can be enhanced to levels equal to or greater than a wild-type
VP22 construct by extension of the domain to either the carboxyl or
Fig. 5. Virion incorporation of VP22 occurs independently of interactions with gE and
VP16. gD-expressing Vero cells (VD60 cells) were transfected with the indicated VP22–
GFP constructs, and 20 h later, they were infected with a gE/gD-null virus [vRR1097/
gEβ]. After an additional 18-h incubation, cell lysates were prepared (A) and virions
were collected from themedia by centrifugation through a 30% sucrose cushion (B). Cell
lysates and extracellular virus were separated by SDS–PAGE and transferred to
nitrocellulose. Western blot analysis was performed using a rabbit polyclonal antibody
speciﬁc for GFP. As a loading control, the blot was stripped and reprobed with a rabbit
monospeciﬁc polyclonal antibody raised against the HSV-1 major capsid protein VP5.
The blots were also probed with antibodies speciﬁc for gD and gE. The positions of
molecular mass markers (in kilodaltons) are indicated on the left. (C) Packaging
efﬁciency. Using densitometry, packaging efﬁciency was quantitated by dividing the
amount of VP22–GFP protein detected in extracellular virus particles (normalized for
VP5) by the amount in the cell lysate (normalized for VP5). In each experiment, the
wild-type VP22–GFP construct was set at 100% packaging efﬁciency. Error bars
represent standard deviations for four replicate experiments.
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levels below those of a wild-type construct (data not shown).
To determine whether VP22 constructs that facilitate wild-type
levels of binding to both VP16 and gE are packaged into virions at
levels equivalent to VP22–GFP, we utilized the transfection/infection-
based packaging assay described above. A wild-type HSV-1 strain was
used to infect the transfected monolayers, allowing any contribution
of heretofore unknown VP22 packaging determinants to be ascer-
tained. Western blot analysis of the various VP22–GFP constructs
within transfected/infected cells showed that the mutants were
expressed at levels similar to wild-type VP22 and migrated at the
expectedmolecular weight (Fig. 7A).With regard to packaging, VP22–
GFP was incorporated into virus particles, whereas GFP alone was
undetectable, despite high expression in the transfected/infected cells
(Figs. 7B and C). As we had seen previously, VP22.165–270 which
binds to VP16 and gE was incorporated to approximately 49% of wild-type levels. In contrast, upon deletion of residues 165–270, VP22
virion packaging occurred at extremely low (approximately 8% of
wild-type VP22) but reproducible levels (Figs. 7B and C). A virion
packaging signal has been described in the C-terminus of VP22 and is
contained within VP22.Δ165-270, perhaps accounting for the low
levels of incorporation seen with this mutant (Schlegel and Blaho,
2009).
VP22.87-301, which displayed wild-type binding to both VP16 and
gE (Fig. 6 and data not shown), was not packaged at wild-type levels
but at an efﬁciency comparable to VP22.165-270 (Figs. 7B and C).
Similar results were attained with VP22.121-301 and VP22.165-301.
However, upon inclusion of residues 44–86, incorporation into virus
particles returned to levels resembling VP22–GFP (95%) (Figs. 7B and
C). These results suggest that optimal VP22 incorporation levels are
not facilitated by wild-type binding to both VP16 and gE alone, but
require residues 44–86 of VP22.
Localization of VP22 to the TGN is facilitated by an acidic cluster
of amino acids
HSV-1 virion components must trafﬁc to the TGN for incorporation
into virus particles. Some virion proteins trafﬁc to the TGN as a
multiprotein complex (e.g. nucleocapsids), whereas other structural
proteins likely target to the TGN as monomers. Trafﬁcking signals are
usually short amino acid motifs within a protein that can be classiﬁed
into three general categories: tyrosine-based motifs (YXXΦ), dileucine
motifs and acidic cluster motifs (Bonifacino, 2004; Kirchhausen, 1999;
Kirchhausen et al., 1997; Wan et al., 1998). The negatively charged
amino acids within acidic clusters are thought to interact with
components of the clathrin sortingmachinery at the plasmamembrane
as well as endosomal and Golgi compartments. A variety of herpesvirus
proteins have hijacked these cellular mechanisms, including the
tegument protein UL11 and glycoproteins gB, gE, and gI, which contain
dileucine and acidic clustermotifs that enable these proteins to trafﬁc to
the TGN (Alconada et al., 1998, 1999; Loomis et al., 2001; McMillan and
Johnson, 2001; Tugizov et al., 1999).
Analysis of the primary structure of amino acids 44–86 of VP22,
which facilitate wild-type levels of virion incorporation, reveals a
cluster of acidic amino acids between residues 61–77. To determine if
the putative acidic cluster within VP22 is required for targeting to the
TGN, we examined the localization of a variety of VP22 mutants that
lacked this motif. Residues comprising the primary acidic cluster
(amino acids 71–77) were changed to alanines (AC→Ala) or deleted
(ΔAC1) (Fig. 8A). A smaller cluster of acidic amino acids is also located
at residues 61–64 of VP22. To eliminate the possibility that deletion
mutagenesis may enable this secondary motif to functionally
substitute for the primary acidic cluster, we deleted both motifs,
creating the mutant ΔAC1+ΔAC2 (Fig. 8A). Finally, if the acidic cluster
of VP22 is necessary for localization to the TGN, then the localization
of VP22 acidic cluster deletion mutants should be restored by
insertion of other well-characterized acidic clusters into VP22. The
acidic cluster of the cellular protein furin (SDSEEDE) was inserted into
VP22 in the same position as the native acidic cluster (Fig. 8A).
Development of an assay to differentiate between the cellular
localization of wild-type VP22 and various acidic cluster mutants was
hindered due to the nature of VP22 relative to other well-
characterized proteins containing acidic cluster motifs. First of all,
VP22 appears to be a peripheral membrane protein (Brignati et al.,
2003). Additionally, VP22 fails to accumulate at the plasma mem-
brane, rendering classical endocytosis assays inaccessible. Therefore,
we examined the localization of the VP22 acidic cluster mutants
relative to that of AP-1, a major clathrin adaptor protein of the TGN
using confocal microscopy (Fig. 8B).
Vero cells were transfected with GFP-tagged versions of the
constructs represented in Fig. 8A, and 20 h later, they were infected
with HSV-1. At 18 h post-infection (38 h post-transfection), cells were
Fig. 6. Co-immunoprecipitation of gE and VP16 with VP22 truncation mutants. (A) VP22 truncation mutants fused to GFP. A schematic representation of full-length and N-terminal
truncationmutants of VP22 fused to the N-terminus of the GFP protein. Also represented, deletion of the region of VP22 that facilitates binding to both VP16 and gE and this domain alone
fused to GFP. (B) Expression of VP22 mutants in transfected/infected cells. Vero cells were transfected with the VP22–GFP constructs represented in Fig. 6A, and 20 h later, they were
infected with a VP22-null virus [UL49−]. After an additional 10-h incubation, the cells were lysed with NP-40 lysis buffer. A fraction of each cell lysate was analyzed byWestern blotting
using a goat polyclonal antibody speciﬁc for GFP. The remainder of the transfected/infected cell lysate was incubatedwith a goat polyclonal antibody against GFP and resulting antibody–
antigen complexeswere collectedwith proteinG-agarose beads.After extensivewasheswith lysis buffer,material that immunoprecipitatedwith anti-GFP antibodywas separatedbySDS–
PAGE and transferred to nitrocellulose. Co-immunoprecipitated gE (C) and VP16 (D) were detected by immunoblot using a rabbit polyclonal antibody speciﬁc for gE or a rabbit
monospeciﬁc polyclonal antibody raised against a C-terminal peptide of VP16. The positions of molecular mass markers (in kilodaltons) are indicated on the left.
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against AP-1. Confocal microscopy indicated that inactivation of the
acidic cluster by alanine mutagenesis resulted in a dispersed punctate
ﬂuorescence relative to the concentrated punctate ﬂuorescence which
colocalizes with AP-1 that wild-type VP22 exhibits. Deletion of the
primary acidic cluster resulted in an intermediate phenotype with
some dispersed puncta reminiscent of AC→Ala and modest coloca-
lization with AP-1. Interestingly, ΔAC1+ΔAC2 exhibited a dispersed
punctate ﬂuorescence with minimal colocalization with AP-1,
suggesting that the secondary acidic cluster may be able to
functionally substitute upon deletion of the primary cluster. Similar
to wild-type VP22, the acidic cluster from furin efﬁciently localized
VP22 to a similar cellular compartment as AP-1 (Fig. 8B), suggesting
that the acidic cluster motif of VP22 is functionally equivalent to other
well-characterized acidic clusters. Collectively, these results indicate
that the acidic cluster of VP22 facilitates localization to the TGN.Deletion of the acidic cluster of VP22 does not abrogate interaction with
VP16 or gE
Prior to examining whether the packaging determinant that, in
tandemwith optimal gE and VP16 binding, facilitates wild-type levels
of VP22 incorporation is in fact the acidic cluster motif, we needed to
ensure that mutagenesis of the acidic clusters did not have a
detrimental effect on binding to gE and VP16. The acidic clustermutants were assayed for binding in a GST pull-down assay using
VP16 (Fig. 9) or the cytoplasmic tail of gE (Fig. 10) as bait.
Expression analysis of the various acidic cluster mutants within
transfected cells showed that each was expressed and migrated at the
expected molecular weight (Figs. 9A and C). With regards to VP16
binding, VP22–HA was efﬁciently pulled-down from transfected cell
lysates by GST-VP16; however, AC→Ala failed to bind, suggesting
that the structural conformation of VP22 may be sensitive to alanine
mutagenesis (Figs. 9B and E). In contrast, deletion of one or both of the
acidic clusters from VP22 had little impact upon interactionwith VP16
(Figs. 9B and E). Also, substitution of the furin acidic cluster had
minimal effects on VP16 binding (Figs. 9D and E).
Similar results were seen with GST-gECT, with VP22–HA and the
acidic cluster deletion mutants binding efﬁciently, whereas AC→Ala
abrogated interaction with gE (Fig. 10). These results suggest that
mutation of the acidic cluster does not have a detrimental effect on
binding of VP22 to gE or VP16.
An acidic cluster is required to facilitate wild-type levels of VP22
virion packaging
To elucidate the role of the acidic cluster in virion incorporation
of VP22, we utilized the packaging assay described above. Western
blot analysis of the acidic cluster mutants of VP22 within
transfected/infected cells showed that the mutants were expressed
at levels similar to wild-type VP22 and migrated at the expected
Fig. 7. Virion incorporation of VP22 truncation mutants in the presence of a wild-type HSV-1 infection. Expression of the indicated VP22–GFP constructs in transfected/infected cells
(A) and their incorporation into virus particles (B) were analyzed as described in the legend to Fig. 4 with a wild-type HSV-1 strain used for infection rather than a VP22-null virus.
The positions of molecular mass markers (in kilodaltons) are indicated on the left. Packaging efﬁciency (C) was calculated as described in the legend to Fig. 4C, using the tegument
protein VP16 as a loading control rather than VP5. Error bars represent standard deviations for four replicate experiments. Comparison of VP22.87-301 to both wild-type VP22 and
VP22.44-301 indicates that the difference in incorporation levels observed is statistically signiﬁcant (Pb0.001). The difference in packaging levels between VP22.44-301 and the full-
length protein is not signiﬁcant (PN0.05).
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assembling virus particles; however, AC→Ala failed to be incorpo-
rated, presumably due to structural defects ensuing from insertion
of seven consecutive alanines (Fig. 11E). Upon deletion of the
primary acidic cluster (residues 71–77 of VP22), an intermediate
phenotype was observed (Figs. 11B and E). ΔAC1 failed to attain
wild-type levels of incorporation (77%) yet was more efﬁciently
packaged than VP22.87-301 (51%) (Fig. 7C). However, upon
deletion of both acidic clusters from VP22 (ΔAC1+ΔAC2), packaging
was reduced to levels similar to VP22.87-301. This ﬁnding further
suggests that the secondary acidic cluster may partially substitute
for the absence of the primary motif. In addition, the furin acidic
cluster substitution mutant was incorporated into virus particles at
near wild-type levels (Fig. 11E), indicating that a foreign acidic
cluster can functionally substitute for the role of the VP22 acidic
cluster in virion packaging. Collectively, these results suggest that
an acidic cluster of amino acids is required to ensure localization
of VP22 at the TGN and to facilitate efﬁcient incorporation of VP22
into the virion. To our knowledge, this is the ﬁrst description of
a VP22 trafﬁcking signal with functional signiﬁcance for virion
incorporation.Discussion
The HSV-1 tegument protein VP22 is packaged into virions during
ﬁnal envelopment as nucleocapsids bud into TGN-derived vesicles
(Miranda-Saksena et al., 2002). This observation suggests that VP22
trafﬁcs to the TGNwhere interactions with viral glycoproteins, perhaps
in concert with binding to tegument proteins located on the surface of
cytoplasmic capsids ensures tegumentation of the protein.
In support of this model, VP22 binds to the viral envelope proteins
gM, gD, gE, and US9, while the VP22 homologue of the related
alphaherpesvirus, PRV, interacts with the cytoplasmic tails of gE and
gM(Brignati et al., 2003; Chi et al., 2005; Fuchs et al., 2002;O'Regan et al.,
2007a; O'Regan et al., 2007b; Stylianou et al., 2009). Furthermore, VP22
interacts with VP16, whose presence on the surface of capsids
undergoing secondary envelopment may facilitate packaging of VP22
into the tegument (Elliott et al., 1995; Miranda-Saksena et al., 2002;
Naldinho-Souto et al., 2006). A previous study demonstrated that the gE
binding domain of VP22 (residues 165–270), which also facilitates
binding to VP16, is packaged into assembling virions (O'Regan et al.,
2007a). Interestingly, VP16 binding is not essential for incorporation of
VP22 into virions (O'Regan et al., 2007b). Thus, to further elucidate the
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Fig. 9. Characterization of the ability of VP22 acidic cluster motif mutants to bind to VP16 in a GST pull-down assay. Expression of VP22 acidic cluster motif mutants in transfected
Vero cells (A and C), their ability to bind to VP16 (B and D), and binding efﬁciency (E) were analyzed as described in the legend to Fig. 3, with Western blot analysis performed with
an HA-speciﬁc antibody rather than one speciﬁc for GFP. The positions of molecular mass markers (in kilodaltons) are indicated on the left. Error bars represent standard deviations
for four replicate experiments.
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our studies have focused on deﬁning the functional signiﬁcance of gE
binding on incorporation of VP22 into the tegument.
To abrogate the VP22–gE interactionwithminimal disruption to the
overlapping VP16 binding activity, residues 165–270 of VP22 were
subjected to extensive point mutagenesis. A variety of point mutants
which abrogated gE binding, but not that of VP16, were packaged into
assembling virus particles, albeit at reduced levels. It is unclear whether
the observed reduction in packaging is a result of the inability of these
mutants to bind to gE or is due to the impaired VP16 binding that occurs
upon mutation of VP22. Nevertheless, these results indicate that gE
binding is not absolutely required for virion incorporation of VP22.
In contrast to our ﬁndings, a recent report from Stylianou and
coworkers described an internal deletion of 14 amino acids withinFig. 8.Mutagenesis of the acidic cluster motifs of VP22. (A) Acidic cluster motif mutants of V
the primary acidic cluster of VP22 to alanine residues, deletion of the primary acidic cluster
construct in which the primary acidic cluster is replaced with the acidic cluster from the cellu
Vero cells were transfected with GFP-tagged versions of the constructs represented in Fig
transfection), cells were ﬁxedwith paraformaldehyde and permeabilizedwith Triton X-100.
anti-mouse IgG antibody conjugated to Alexa Fluor 555. Panels within the same row are the
(column I) or Alexa Fluor 555 (column II), and these images were digitally combined to prVP22 which abrogated binding to gE and dramatically reduced
packaging of VP22 into the virus particle, suggesting that gE is a
major determinant of VP22 incorporation (Stylianou et al., 2009).
Throughout our studies of VP22, we have noted that the protein
seems to be exquisitely sensitive to mutation, with even single
point mutations resulting in loss of multiple activities. Interesting-
ly, the VP22 construct described by Stylianou and colleagues,
although retaining the ability to bind to VP16, does exhibit
decreased binding to the cytoplasmic tail of gM. Thus, we
hypothesize that the internal deletion within VP22 in addition to
abrogating gE binding may have inadvertently disrupted unidenti-
ﬁed activities of VP22 which facilitate virion incorporation; activities
presumably unaffected by the VP22 point mutants characterized in
this study.P22. Schematic representation of HA-tagged VP22 and constructs with either, mutation of
, or deletion of both primary and secondary acidic clusters from VP22. A VP22 HA-tagged
lar protein furin is also represented. (B) Localization of VP22 acidic cluster motif mutants.
. 8A, and 20 h later, they were infected with HSV-1. At 18 h post-infection (38 h post-
Cells were labeled with amonoclonal antibody against AP-1, which was detected by a goat
same ﬁeld viewed by confocal microscopy with the appropriate wavelength to excite GFP
oduce the image in column III.
Fig. 10. Characterization of the ability of VP22 acidic cluster motif mutants to bind to the cytoplasmic tail of gE in a GST pull-down assay. Expression of VP22 acidic cluster motif
mutants in transfected Vero cells (A and C), their ability to bind to the cytoplasmic tail of gE (B and D), and binding efﬁciency (E) were analyzed as described in the legend to Fig. 1,
with Western blot analysis performed with an HA-speciﬁc antibody rather than one speciﬁc for GFP. The positions of molecular mass markers (in kilodaltons) are indicated on the
left. Error bars represent standard deviations for four replicate experiments.
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incorporation was further highlighted when we examined the
possible redundancy that VP16 and gE binding may play in VP22
virion packaging. As addition of VP22 to the tegument is also
independent of interaction with VP16, we speculated that both
binding activities (gE and VP16) could act in a redundant, or perhaps
additive fashion, to facilitate virion packaging of VP22. Functional
redundancy is a common theme across herpesvirology, at least for
virus growth in cell culture (Brack et al., 1999, 2000; Fuchs et al.,
2002). However, studies examining the incorporation of a VP22
construct deﬁcient in VP16 binding into a gE-null virus indicate that
gE and VP16 binding do not act in a redundant fashion. This is not
overly surprising, as VP22 has additional binding partners including
gM, gD, US9, and the membrane associated protein pUL46 (Chi et al.,
2005; Lee et al., 2008; Stylianou et al., 2009). Furthermore, it has also
been suggested that the C-terminus of VP22 may contain an
incorporation determinant of VP22 (Hafezi et al., 2005; Schlegel and
Blaho, 2009). However, mutants which harbor this region, in addition
to maintaining gE and VP16 binding activities, are still packaged at
reduced levels.In support of the concept that additional incorporation determinants
exist, a VP22 construct (VP22.87-301),which binds to both VP16 and gE
at wild-type levels, is not incorporated into virus particles at wild-type
levels; however, wild-type levels of incorporation were attained when
aminoacids 44–301of VP22were examined (Fig. 7). This result suggests
that the additional incorporation determinants for VP22 are putatively
locatedwithin residues44–86. ThedomainsofVP22which interactwith
gD, US9, and pUL46 have not been characterized; however, a conserved
acidic cluster of amino acids is found within this region of VP22
encompassing residues 61–77.
Acidic clusters are well-characterized trafﬁcking motifs, shuttling
proteins to and from the Golgi apparatus. Considering the dynamic
nature of the TGN, onewould anticipate that a resident protein such as
VP22 would contain sorting sequences that facilitate its vesicular
trafﬁcking and retrieval (Brignati et al., 2003). Many herpesvirus
proteins utilize such motifs to localize to the TGN (Alconada et al.,
1998; Alconada et al., 1999; Loomis et al., 2001; McMillan and
Johnson, 2001; Tugizov et al., 1999). Furthermore, an acidic cluster of
amino acids appears to be required for virion incorporation of the
HSV-1 tegument protein UL11; however, this motif is not sufﬁcient, as
Fig. 11. Virion incorporation of VP22 acidic cluster motif mutants. Expression of the indicated VP22–HA constructs in transfected/infected cells (A and C) and their incorporation into
virus particles (B and D) were analyzed as described in the legend to Fig. 4, with Western blot analysis performed with an HA-speciﬁc antibody rather than one speciﬁc for GFP. The
positions of molecular mass markers (in kilodaltons) are indicated on the left. (C) Packaging efﬁciency. Using densitometry, packaging efﬁciency was quantitated by dividing the
amount of VP22–HA protein detected in extracellular virus particles (normalized for VP5) by the amount in the cell lysate (normalized for VP5). Error bars represent standard
deviations for four replicate experiments. Comparison of ΔAC1 and ΔAC1+ΔAC2 to each other and to wild-type VP22 indicates that the difference in incorporation levels observed is
statistically signiﬁcant (Pb0.001). The difference in packaging levels between wild-type VP22 and a construct in which the primary acidic cluster of VP22 is replaced with that of
furin is not signiﬁcant (PN0.05).
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branes are not packaged into virus particles (Loomis et al., 2006).
Mutational analysis of the acidic cluster of VP22 demonstrated that
the motif is required to facilitate both TGN localization and wild-type
levels of incorporation of VP22 into the virion (Figs. 8 and 11).
Furthermore, upon deletion of the primary acidic cluster from VP22, a
secondary group of acidic amino acids, encompassing residues 61–64,
could in some measure, functionally substitute. Deletion of the acidic
cluster motif had no detrimental effect on the gE and VP16 binding
activities of VP22 (Figs. 9 and 10); however, the effect on other VP22
binding activities was not determined. Thus, although one cannot rule
out the possible contribution of gD, US9, or pUL46 binding or otherunidentiﬁed activities which may map to this region of VP22, the
results suggest that the acidic cluster facilitates efﬁcient incorporation
of VP22 into the virion.
Interestingly, two VP22 point mutants (W189F/W221F and
F201A) which are both unable to interact with either VP16 or gE
(Figs. 1–3) localize to a subcellular compartment reminiscent of the
TGN (data not shown). These constructs harbor the acidic cluster
motif and residues 165–225 (which facilitate membrane association
of VP22); however, neither VP22 mutant was packaged into virus
particles [Fig. 4 and (O'Regan et al., 2007b)]. This ﬁnding suggests that
in a similar fashion to UL11, localization to the putative site of ﬁnal
envelopment is not sufﬁcient to facilitate virus packaging of VP22, and
190 K.J. O'Regan et al. / Virology 405 (2010) 176–192additional determinants are required (presumably protein–protein
interactions which are disrupted by the point mutations present in
these VP22 constructs).
A logical model would suggest that VP22 must ﬁrst associate with
membranes through the actions of the membrane association domain
and then localize to the TGN via the acidic cluster motif. The converse is
unlikely to occur because acidic clustermotifs aremembrane trafﬁcking
motifs and would require membrane association for functionality. After
localization to the TGN, protein–protein interactions ensure retention of
VP22 in the assembly pathway with resultant incorporation into
assembling virus particles. In absence of an acidic cluster, protein
interactions with VP16 and gE (or other binding partners) may only
recruit a portion of VP22 into the assembly pathway (perhaps through
encounters with VP16-coated capsids, or with the cytoplasmic tail of gE
as VP22 trafﬁcs through the TGN).
Materials and methods
Cells and viruses
Vero (ATCC CCL-81) and A7 (human melanoma) cells, a gift from
Gary Thomas (The Oregon Health and Science University, Portland,
Oregon), were grown in Dulbecco's modiﬁed Eagles medium (DMEM)
(GIBCO) supplemented with 10% fetal bovine serum (FBS), 2.25%
sodium bicarbonate, 25 mM HEPES buffer, glutamine (300 μg/ml),
penicillin (100 μg/ml), and streptomycin (131 μg/ml). gD-expressing
Vero cells (VD60 cells), a kind gift from David Johnson [The Oregon
Health and Science University, Portland, Oregon (Farnsworth et al.,
2003)], were grown in media lacking histidine supplemented with
1.2 mM histidinol. Infected cells were grown in DMEM supplemented
with 2% FBS, 25 mM HEPES buffer, glutamine (300 μg/ml), penicillin
(100 μg/ml), and streptomycin (131 μg/ml). The viruses used in this
study were the KOS strain (Smith, 1964), a VP22-null virus (UL49−), a
kind gift from Joel Baines [Cornell University, Ithaca, New York (Duffy
et al., 2006)], and a gE/gD-null virus [vRR1097/gEβ], a kind gift from
David Johnson [The Oregon Health and Science University, Portland,
Oregon (Farnsworth et al., 2003)].
Construction of VP22–GFP and VP22–HA chimeras
Plasmids encoding VP22 fused to GFP, N-terminal truncations of
VP22 fused to GFP, internal deletions of VP22 (pVP22.Δ165-270-GFP
and pVP22.165-270-GFP), and a dileucine motif mutant of VP22
(pVP22.LI(−)-GFP) were described previously (Brignati et al., 2003;
Murphy et al., 2008; O'Regan et al., 2007a,b).
To make plasmids encoding the various point mutant variants of
VP22, the QuikChange XL Site-Directed Mutagenesis Kit (Stratagene)
was used according to the manufacturer's instructions. Using pVP22–
GFP as a template (Brignati et al., 2003), mutagenic primers were
designed which changed the nucleotide sequence of codon 189 of
VP22 to encode for a phenylalanine residue rather than a tryptophan,
thereby creating pVP22.W189F-GFP. A similar strategy was used to
create pVP22.W221F-GFP, pVP22.F196A-GFP, pVP22.F196W-GFP,
pVP22.F201A-GFP, and pVP22.F201W-GFP. To construct plasmids
encoding the double point mutant of VP22, W189F/W221F, the
QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) was used
with pVP22.W189F-GFP acting as a template.
The plasmid encoding VP22 fused to the hemagglutinin epitope
(pVP22–HA) has been described previously (O'Regan et al., 2007b). To
construct pVP22.AC→Ala-HA, the QuikChange XL Site-Directed Muta-
genesis Kit (Stratagene) was used according to the manufacturer's
instructions. Using pVP22–HA as a template, mutagenic primers were
designed which changed the nucleotide sequence of codons 71–77 of
VP22 to encode for alanines rather than the residues of the acidic cluster
motif. This QuikChange XL Site-DirectedMutagenesismethodologywas
also utilized to make pVP22.ΔAC1–HA. Mutagenic primers weredesigned complementary to 15-bp immediately upstream of codon 71
and 15-bp immediately downstream of codon 77, essentially looping
out the sequence encoding amino acids 71–77 of VP22 in pVP22–HA.
Using pVP22.ΔAC1–HA as a template, a similar approach was used to
construct pVP22.ΔAC1+ΔAC2–HA.
The furin acidic cluster was introduced into VP22 through
QuikChange mutagenesis. Mutagenic primers were designed to
encode the acidic cluster of furin (TCC GAC TCG GAA GAA GAC GAA)
and ﬂank both the upstream and downstream sequence of the VP22
acidic cluster with 12 complementary nucleotides.
To create GFP-tagged versions of the acidic cluster motif mutants of
VP22, DNA was ampliﬁed from the respective HA-tagged acidic cluster
constructs by using a forward primer containing a BglII site 92-bp
upstream of the start codon of VP22 and a reverse primer containing a
HindIII site immediately downstream of codon 301 of VP22. This
product was digested with BglII and HindIII and ligated into the vector
pEGFP-N2 (Clontech) digested with the same restriction enzymes to
produce pVP22.AC→Ala-GFP, pVP22.ΔAC1-GFP, pVP22.ΔAC1+ΔAC2-
GFP, and pVP22.FurinAC-GFP.
All constructs were sequenced to conﬁrm the identity of VP22 and
to ensure that the gene encoding VP22 (or mutated forms) was in
frame with the gene encoding the GFP protein or the sequence that
encodes the HA tag.
Construction and puriﬁcation of GST fusion proteins
Construction of the plasmid encoding VP16 fused to the C-
terminus of the GST protein (GST-VP16) was described previously
(O'Regan et al., 2007b). The vector encoding the cytoplasmic tail of gE
fused to GST (GST-gECT) was a kind gift from David Johnson (The
Oregon Health and Science University, Portland, Oregon).
To express and purify the various GST fusion proteins, plasmids
encoding the respective constructs were transformed into BL21
competent cells (Stratagene) according to the manufacturer's instruc-
tions and overnight cultures were prepared. Approximately 10 ml of
these cultures was used to inoculate fresh 100-ml cultures, which
were subsequently grown at 37 °C to A600=0.4. To induce expression,
100 μL of 1 M IPTG (GIBCO) was added and the cultures were grown at
30 °C for 3–4 h, followed by centrifugation at 10,000×g for 10 min at
4 °C. The bacterial pellet was resuspended in 10 ml of lysis buffer
(100 mM Tris–HCl [pH 8.0], 1 mM EDTA, 1 mM CHAPS, 400 mM NaCl,
1% Triton X-100, Complete Mini protease inhibitors [Roche]). The
suspension was sonicated and clariﬁed by centrifugation at 27,000×g
for 10 min at 4 °C. A volume of 133 μl of glutathione–Sepharose 4B
beads (Pharmacia) that had been washed twice with phosphate-
buffered saline (PBS) was added to the supernatant and incubated
overnight at 4 °C. Beads were washed thoroughly with PBS and the
yield of each puriﬁed GST fusion protein was determined by SDS–
PAGE and subsequent staining with Coomassie blue to detect the
recombinant protein.
GST pull-down assay
To analyze the VP22–gE and VP22–VP16 interaction within
transfected cells, a GST pull-down assay was used. Conﬂuent mono-
layers of Vero cells grown in 100-mm plates were transfected with the
indicated constructs by using Lipofectamine 2000 (Invitrogen), accord-
ing to the manufacturer's instructions. At 20 h post-transfection,
monolayers were washed twice with PBS and scraped into 10 ml of
cold PBS. A 1-ml sample of the cell suspensionwas removed for analysis
of expression of the VP22–GFP or VP22–HA fusion proteins, and the
remaining cells were pelleted by centrifugation (1000×g for 5 min at
4 °C) and lysed in NP-40 lysis buffer (1% NP-40, 200 mM NaCl, 50 mM
Tris–HCl [pH 7.4], 2 mM MgCl2). Transfected cell lysates were
precleared overnight at 4 °C with glutathione–Sepharose 4B beads
that had been previously washed twicewith PBS, and the samples were
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fusion proteins on glutathione–Sepharose beads (as determined by
Coomassie-blue-stained gel) for 3 h at 4 °C. Beads were washed three
times with NP-40 lysis buffer and once with 10 mM Tris–HCl (pH 7.4).
GFP or HA-tagged VP22 fusion proteins bound to GST constructs were
detected by Western blotting using a rabbit polyclonal antibody raised
against the GFP protein (Santa Cruz) or a rabbit polyclonal antibody
speciﬁc for the hemagglutinin epitope (Sigma), a goat anti-rabbit
antibody conjugated to horseradish peroxidase (Sigma), ECL reagents
(Pharmacia), and autoradiography on Kodak BioMax XAR ﬁlm. To
further control for the quantities of GST fusion proteins used in the pull-
down, nitrocellulose membranes were stripped (60 mM Tris–HCl [pH
8.0], 2% SDS, 0.75% β-mercaptoethanol [β-ME] for 45 min at 55 °C) and
reprobedwith a goat polyclonal antibody raised against the GST protein
(Rockland). To detect expression of the VP22–GFP or VP22–HA fusion
proteins in transfected cells, proteins in the 1-ml cell suspension sample
were analyzed by Western blotting using a rabbit polyclonal antibody
against GFP or the hemagglutinin epitope, a goat anti-rabbit antibody
conjugated to horseradish peroxidase, ECL reagents, and autoradiogra-
phy on Kodak BioMax XAR ﬁlm. To ensure equal loading, nitrocellulose
membraneswere stripped as described above and reprobedwith a goat
polyclonal antibody raised against actin (Santa Cruz). Using densitom-
etry, binding efﬁciency was quantitated by dividing the amount of
VP22–GFP or VP22–HA fusion protein detected in the pull-down assay
(normalized for the amount of GST-VP16 or GST-gECT present) by the
amount in the cell lysate (normalized for the amount of actin present).
Immunoprecipitation–Western assay
Conﬂuent monolayers of Vero cells grown in 100-mm plates were
transfected with the indicated constructs by using Lipofectamine
2000 (Invitrogen), according to the manufacturer's instructions. At
20 h post-transfection, the monolayers were infected with HSV-1 KOS
strain or a VP22-null virus [UL49−] at an MOI of 10. At 10 h post-
infection (30 h post-transfection), cells were washed twice with PBS
and scraped into 10 ml of cold PBS. A 1-ml sample of the cell
suspension was removed for analysis of expression of the VP22–GFP
fusion proteins, and the remaining cells were pelleted by centrifuga-
tion (1000×g for 5 min at 4 °C). The 9-ml samples were lysed in NP-40
lysis buffer containing Complete Mini protease inhibitors as described
above and precleared overnight at 4 °C with protein G-agarose beads
(Roche) that had been washed twice in lysis buffer. The lysates were
then incubated with a goat polyclonal antibody raised against GFP
(Rockland) for 1 h at 4 °C, and immune complexes were collected
with protein G-agarose beads that had been washed twice with lysis
buffer. Beads were washed three times with NP-40 lysis buffer and
once with 10 mM Tris–HCl (pH 7.4). Co-immunoprecipitated VP16
and gE were detected by immunoblot using a rabbit monospeciﬁc
polyclonal antibody raised against a C-terminal peptide of the HSV-1
tegument protein VP16 (Clontech) or a rabbit polyclonal antibody
speciﬁc for gE (a kind gift from Harvey Friedman, University of
Pennsylvania, Philadelphia, Pennsylvania), a goat anti-rabbit antibody
conjugated to horseradish peroxidase, ECL reagents, and chemilumi-
nescence autoradiography on Kodak BioMax XAR ﬁlm. To detect
expression of the VP22–GFP fusion proteins in transfected/infected
cells, proteins in the 1-ml cell suspension sample were analyzed by
Western blotting using a goat polyclonal antibody against GFP, a
rabbit anti-goat antibody conjugated to horseradish peroxidase, ECL
reagents, and autoradiography on Kodak BioMax XAR ﬁlm.
Virion incorporation assay
Conﬂuent monolayers of Vero cells or gD-expressing Vero cells
(VD60 cells) grown in 100-mm plates were transfected with the
indicated constructs using Lipofectamine 2000 (Invitrogen), according
to the manufacturer's instructions. At 20 h post-transfection, cells wereinfected with either HSV-1 KOS strain, a VP22-null virus (UL49−), or a
gE/gD-null virus [vRR1097/gEβ] at an MOI of 10, or mock infected. At
18 h post-infection (38 h post-transfection), the medium was removed
by pipetting and centrifuged at 1000×g for 10 min at 4 °C to remove
cellular debris. The supernatant was retained and extracellular virions
were puriﬁed by centrifugation (115,000×g for 1 h in a Beckman SW41
rotor) through a 30% (wt/vol) sucrose cushion (1.7 ml) in NTE buffer
(100 mMNaCl, 10 mM Tris, 1 mM EDTA, [pH 7.4]). Pelleted virions and
infected cells were disrupted in 1× sample buffer (50 mM Tris–HCl [pH
6.8], 10% glycerol, 2% SDS, 5% β-ME). GFP or HA-tagged proteins were
detected by Western blotting using a goat polyclonal antibody raised
against the GFP protein (Rockland) or a rabbit polyclonal antibody
speciﬁc for the hemagglutinin epitope (Sigma), followed by the
appropriate secondary antibody conjugated to horseradish peroxidase,
ECL reagents, and chemiluminescence autoradiography on Kodak
BioMax XAR ﬁlm. As a loading control, nitrocellulose membranes
were stripped as described above and reprobed with either a rabbit
polyclonal antibody raised against the major capsid protein VP5 or a
rabbit monospeciﬁc polyclonal antibody raised against a C-terminal
peptide of the HSV-1 tegument protein VP16 (Clontech). As an
additional control when using the gE/gD-null virus [vRR1097/gEβ],
blots were probed for gD and gE. Using densitometry, packaging
efﬁciency was quantitated by dividing the amount of VP22–GFP or
VP22–HAprotein detected in extracellular virus particles by the amount
in the cell lysate (both normalized for either VP5 or VP16).
Confocal microscopy
Vero cells were transfected with the indicated constructs using
Lipofectamine 2000 (Invitrogen), according to the manufacturer's
instructions. At 20 h post-transfection, cells were infected with HSV-1
KOS strain at an MOI of 10 or mock infected. At 18 h post-infection
(38 h post-transfection), cells were washed twice in Tris-buffered
saline (TBS), ﬁxed with 3% paraformaldehyde in PBS, and permeabi-
lized with 0.1% Triton X-100 in PBS. Cell monolayers were incubated
for 1 h with a monoclonal antibody raised against AP-1 (Sigma). The
cells were then reacted with a goat anti-mouse IgG antibody
conjugated to Alexa Fluor 555 (Molecular Probes) and mounted on
slides using SlowFade antifade reagent with DAPI (Molecular Probes).
Intrinsic GFP ﬂuorescence was observed using a Leica TSC SP2 AOBS
confocal microscope using the 488-nm laser line, while immunoﬂu-
orescence was detected using the 543-nm laser line. Images were
formatted in Adobe Photoshop 7.0.
Statistical analysis
For all statistical considerations, the data were normalized to the
control prior to analysis. Statistical calculations were performed using
GraphPad Prism version 5 software. One-way analysis of variance
(ANOVA) was used with Bonferroni post test analysis. Statistical
signiﬁcance was set to at least p-valueb0.05.
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